Listen now | Tom Pesnot is the head of medicinal chemistry at Concept Life Science. I invited him to talk about AI and virtual screening in the drug discovery process. By way of review, Tom laid out the overall process of discovery. One needs to identify a target whose activity can be modulated in a way that is of course, relevant to the disease of interest. Most often we are trying to stop a protein from carrying out its normal function.